1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Energy Partitioning in Multicomponent Nanoscintillators for Enhanced Localized Radiotherapy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Multicomponent nanomaterials consisting of dense scintillating particles functionalized by or embedding optically active conjugated photosensitizers (PSs) for cytotoxic reactive oxygen species (ROS) have been proposed in the last decade as coadjuvant agents for radiotherapy of cancer. They have been designed to make scintillation-activated sensitizers for ROS production in an aqueous environment under exposure to ionizing radiations. However, a detailed understanding of the global energy partitioning process occurring during the scintillation is still missing, in particular regarding the role of the non-radiative energy transfer between the nanoscintillator and the conjugated moieties which is usually considered crucial for the activation of PSs and therefore pivotal to enhance the therapeutic effect. We investigate this mechanism in a series of PS-functionalized scintillating nanotubes where the non-radiative energy transfer yield has been tuned by control of the intermolecular distance between the nanotube and the conjugated system. The obtained results indicate that non-radiative energy transfer has a negligible effect on the ROS sensitization efficiency, thus opening the way to the development of different architectures for breakthrough radiotherapy coadjutants to be tested in clinics.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: not found

          Photodynamic therapy for cancer.

          The therapeutic properties of light have been known for thousands of years, but it was only in the last century that photodynamic therapy (PDT) was developed. At present, PDT is being tested in the clinic for use in oncology--to treat cancers of the head and neck, brain, lung, pancreas, intraperitoneal cavity, breast, prostate and skin. How does PDT work, and how can it be used to treat cancer and other diseases?
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Photodynamic therapy of cancer: An update

            Photodynamic therapy (PDT) is a clinically approved, minimally invasive therapeutic procedure that can exert a selective cytotoxic activity toward malignant cells. The procedure involves administration of a photosensitizing agent followed by irradiation at a wavelength corresponding to an absorbance band of the sensitizer. In the presence of oxygen, a series of events lead to direct tumor cell death, damage to the microvasculature, and induction of a local inflammatory reaction. Clinical studies revealed that PDT can be curative, particularly in early stage tumors. It can prolong survival in patients with inoperable cancers and significantly improve quality of life. Minimal normal tissue toxicity, negligible systemic effects, greatly reduced long-term morbidity, lack of intrinsic or acquired resistance mechanisms, and excellent cosmetic as well as organ function-sparing effects of this treatment make it a valuable therapeutic option for combination treatments. With a number of recent technological improvements, PDT has the potential to become integrated into the mainstream of cancer treatment.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Photosensitized singlet oxygen and its applications

              M DeRosa (2002)
                Bookmark

                Author and article information

                Journal
                ACS Appl Mater Interfaces
                ACS Appl Mater Interfaces
                am
                aamick
                ACS Applied Materials & Interfaces
                American Chemical Society
                1944-8244
                1944-8252
                12 May 2023
                24 May 2023
                : 15
                : 20
                : 24693-24700
                Affiliations
                []Dipartimento di Scienza Dei Materiali, Università Degli Studi Milano-Bicocca , 20125 Milano, Italy
                []NANOMIB, Center for Biomedical Nanomedicine, University of Milano-Bicocca , P.zza Ateneo Nuovo 1, 20126 Milan, Italy
                [§ ]FZU—Institute of Physics of the Czech Academy of Sciences , Cukrovarnická 10/112, 16 200 Prague, Czech Republic
                []Department of Earth and Environmental Sciences, Università Degli Studi Milano-Bicocca , Piazza Della Scienza 4, 20126 Milano, Italy
                Author notes
                Author information
                https://orcid.org/0000-0001-7367-109X
                https://orcid.org/0000-0002-6150-7847
                https://orcid.org/0000-0003-3072-2242
                https://orcid.org/0000-0002-2378-208X
                https://orcid.org/0000-0001-5627-6186
                https://orcid.org/0000-0001-9768-4573
                Article
                10.1021/acsami.3c00853
                10214376
                37172016
                b38c92b1-9327-482f-92f2-dab13ad7e53d
                © 2023 The Authors. Published by American Chemical Society

                Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained ( https://creativecommons.org/licenses/by/4.0/).

                History
                : 18 January 2023
                : 28 April 2023
                Funding
                Funded by: H2020 Spreading Excellence and Widening Participation, doi 10.13039/100010684;
                Award ID: 101003405
                Funded by: Ministero degli Affari Esteri e della Cooperazione Internazionale, doi 10.13039/501100006601;
                Award ID: H45H19000070001
                Funded by: Ministero della Salute, doi 10.13039/501100003196;
                Award ID: RF-2016- 02362263
                Funded by: Ministerstvo Školství, Mládeže a Telovýchovy, doi 10.13039/501100001823;
                Award ID: CZ.02.1.01/0.0/0.0/16_019/0000
                Funded by: European Commission, doi 10.13039/501100000780;
                Award ID: NA
                Categories
                Research Article
                Custom metadata
                am3c00853
                am3c00853

                Materials technology
                radiotherapy,scintillators,energy transfer,singlet oxygen,nanomaterials
                Materials technology
                radiotherapy, scintillators, energy transfer, singlet oxygen, nanomaterials

                Comments

                Comment on this article